Next Article in Journal
Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis
Next Article in Special Issue
New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer—Current State and Molecular Pathology Perspective
Previous Article in Journal
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Previous Article in Special Issue
Menopausal Hormone Therapy in Breast Cancer Survivors
 
 

Order Article Reprints

Journal: Cancers, 2024
Volume: 16
Number: 4188

Article: Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study
Authors: by Anne de Bruijn, Robert-Jan Schipper, Adri C. Voogd, Marleen J. J. Pullens, Johanne G. Bloemen, Linda de Munck, Yvonne E. van Riet, Sabine Siesling, Birgit E. P. Vriens and Grard A. P. Nieuwenhuijzen
Link: https://www.mdpi.com/2072-6694/16/24/4188

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop